VTGN vs WMT · rev $176.0K vs P/E 42, rev $187.94B
VistaGen Therapeutics Inc (VTGN) versus Walmart Inc (WMT) — a side-by-side from cached financials, not a winner call.
VistaGen Therapeutics Inc (VTGN) is a biotechnology company listed on NASDAQ.
Walmart Inc (WMT) is a discount stores company listed on US. It is led by Doug McMillon.
Latest reported VTGN revenue for 2023-03-31 was $176.0K. Net income was -$12.2M. VTGN currently screens at market cap $28.1M.
Latest reported WMT revenue for 2026-07-31 was $187.94B. Net income was $6.37B. Revenue was up 5.7% from 2026-04-30 to 2026-07-31. WMT currently screens at market cap $780.33B and trailing P/E 41.8.
VTGN currently screens at market cap $28.1M. WMT currently screens at market cap $780.33B and trailing P/E 41.8.
Not investment advice. Open the VTGN and WMT stock pages for the full models.
Not investment advice.